Evolent Health Cash Flow - Quarterly (NYSE:EVH)

Add to My Stocks
$23.2 $1.25 (5.69%) EVH stock closing price Aug 13, 2018 (Closing)

The Evolent Health cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Evolent Health profits and Evolent Health debt. Evolent Health had cash and cash equivalents of $295.36M at beginning of the quarter and $254.33M at quarter end of 2018 Q2. Evolent Health cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Evolent Health saw a outflow of $-19.38M from investing activities till 2018 Q2.

View and download details of Evolent Health cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-24.1M-14.06M-69.76M-55.97M-42.84M-23.14M-226.77M-201.58M-186.27M-173.91M
Depreciation Depletion Amortization Cash-Flow21.16M10.29M33.28M21.92M13.97M6.84M177.82M171.32M167.58M163.97M
Net Increase (Decrease) in Assets Liabilities-23.25M-24.71M-7.28M-15.27M-27.2M-24.7M-4.42M3.11M-11.66M-14.42M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.19M3.77M15.81M15.33M11.36M6.24M17.87M13.13M8.44M3.55M
Net Cash from (used by) Operating Activities
-18M-24.7M-27.95M-33.99M-44.71M-34.76M-35.51M-14M-21.91M-20.8M
Increase (Decrease) in Prop Plant And Equipment-20.24M-9.55M-27.84M-21.34M-12.43M-5.97M-15.52M-11.11M-7.26M-3.35M
Acquisition Disposition of Subsidiaires-11.68M-11.67M-3.69M-3.69M-3.24M--82.56M-14M-14.5M-11.5M
Increase (Decrease) in Investments4M8.04M39.27M44.21M20.21M10.6M6.37M1.09M2.1M-
Other Cash Inflow (Outflow) from Investment Activities8.54M--20M-2.16M3.2M--6.09M1.19M1.19M1.19M
Net Cash from (used by) Investment Activities
-19.38M-12.68M-12.26M17M7.73M4.62M-97.79M-22.82M-18.46M-13.65M
Issuance (Purchase) of Equity Shares4.69M1.46M171.02M170.74M3.56M-1.25M1.24M--
Issuance (Repayment) of Debt Securities------121.25M---
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-8.36M-23.06M-5.47M-1.17M-1.17M-0.66M-0.36M-0.36M-0.31M-
Net Cash from (used by) Financing Activities
-3.67M-21.6M165.55M169.57M2.38M-0.12M122.14M--0.2M-
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-41.04M-59M125.33M152.58M-34.58M-30.26M-11.16M-35.94M-40.58M-34.43M
Cash & Equivalents at Beginning of Year295.36M170.02M145.72M-67.89M5.25M----
Cash & Equivalents at Year End254.33M236.36M295.36M287.14M99.97M104.29M134.56M109.77M105.13M111.29M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Evolent Health stock price history and Evolent Health stock comparison chart inevitably reflect its cash flow situation.

  • Evolent Health has cash of $254.33M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Evolent Health stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Evolent Health lost $-18M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-19.38M for EVH till last quarter 2018 Q2 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-3.67M for Evolent Health.

Key Financial Ratios For Evolent Health Cash Flow

FCF margin
0

Quarterly Cash Flow Statements For Evolent Health Inc Peers

Amedisys cash flow, Civitas cash flow, LHC cash flow, MINDBODY cash flow, Marketo cash flow